Skip to main content
. 2015 Nov 13;7(5):6323–6334. doi: 10.18632/oncotarget.6319

Table 1. Relationship between TPD52 expression and clinicopathological features of patients with HCC (n = 154).

Clinicopathologic variables Number TPD52 expression P value
low high
All cases 154 86 68
Age (years) 0.623
 <50 89 51 38
 ≥50 65 35 30
Gender 0.842
 Male 123 70 53
 Female 31 16 15
HBV 0.325
 Negative 21 14 7
 Positive 133 72 61
Tumor size(cm) 0.745
 <5 77 42 35
 ≥5 77 44 33
Tumor number 0.838
 Single 124 70 54
 Mutiple 30 16 14
Liver cirrhosis 1.000
 No 33 19 14
 Yes 121 67 54
Tumor encapsulation 0.662
 None 58 33 25
 Complete 53 31 22
 Incomplete 43 22 21
Serum AFP 0.245
 <400 95 49 46
 ≥400 59 37 22
Histilogical differentiation 0.178
 Well 52 26 26
 Moderate 66 35 31
 Poor 36 25 11
TNM stage 0.011*
 I-II 100 48 52
 III 54 38 16

AFP, alpha-fetoprotein.

*

Statistically significant (P < 0.05).